Zaflart Tablet contains Deflazacort 6 mg, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including but not limited to rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain dermatological disorders. Deflazacort exerts its therapeutic effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing tissue swelling, pain, and immune system overactivity. Zaflart is also utilized in the treatment of specific muscular dystrophies to improve muscle strength and function. The dosage should be individualized based on the severity of the condition and patient response, with careful tapering recommended to avoid adrenal insufficiency upon discontinuation. Common adverse effects may include gastrointestinal disturbances, increased susceptibility to infections, hyperglycemia, and mood changes. Caution is advised in patients with diabetes, hypertension, osteoporosis, or peptic ulcer disease. Regular monitoring of blood pressure, blood glucose, and electrolyte levels is recommended during prolonged therapy. Zaflart Tablet should be used under strict medical supervision to ensure optimal therapeutic outcomes and minimize potential risks associated with corticosteroid therapy.